While BRAF V600E mutations are classically associated with acquired nevi and melanoma, mutations in NRAS, particularly affecting the NRAS/MAPK pathway, are frequently detected in CMN [10,11]. The gene discussed is BRAF; the disease is congenital mesoblastic nephroma.